Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Dose Size and Dosing Frequency: Determination Methods

Dose Size and Dosing Frequency: Determination Methods

Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

Determination of Multiple Dosing Parameters: Loading and Maintenance Doses

A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

Dosage Regimen Designs: Nomograms and Tabulations

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution

The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated from...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

McKittrick-Wheelock Syndrome, a Rare Cause of Nonresponsive Persistent Dyselectrolytemia.

Diagnostics (Basel, Switzerland)·2025

Same author

Exploring the influence of loneliness on cognitive decline: differential effects in Black and White older adults.

The journals of gerontology. Series B, Psychological sciences and social sciences·2025

Same author

Using deep learning generated CBCT contours for online dose assessment of prostate SABR treatments.

Journal of applied clinical medical physics·2025

Same author

Late Toxicity of Prostate Ultrahypofractionated Radiation Therapy Compared With Moderate Hypofractionation in a Randomized Trial.

International journal of radiation oncology, biology, physics·2023

Same author

Validating the accuracy of a novel virtual reality platform for determining implant orientation in simulated primary total hip replacement.

Digital health·2022

Same author

The Impact of a Cyberattack at a Radiation Oncology Department: Immediate Response and Future Preparedness.

Advances in radiation oncology·2022

Search research articles

Related Experiment Video

Updated: Jun 16, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Analysis of RapidArc optimization strategies using objective function values and dose-volume histograms.

Michael Oliver¹, Isabelle Gagne, Carmen Popescu

¹Department of Medical Physics, British Columbia Cancer Agency, Victoria, British Columbia, Canada. moliver8@gmail.com

Journal of Applied Clinical Medical Physics

|February 18, 2010

Summary

This summary is machine-generated.

Optimizing RapidArc radiotherapy plans using specific strategies like adjusting leaf speed and adding arcs significantly improves treatment quality. These findings in phantom studies were confirmed in clinical head and neck cancer cases.

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

Related Experiment Videos

Last Updated: Jun 16, 2026

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Radiation Planning Assistant - A Streamlined, Fully Automated Radiotherapy Treatment Planning System

Published on: April 11, 2018

Area of Science:

Radiation Oncology
Medical Physics
Cancer Treatment

Background:

RapidArc is a new radiotherapy system for treatment planning and delivery.
The Eclipse system offers various optimization strategies to enhance treatment plans.

Purpose of the Study:

To systematically evaluate three optimization strategy categories in RapidArc.
To compare these strategies against a baseline using phantoms and clinical head and neck cases.

Main Methods:

Four phantoms were used to test strategies: modifying initialization, increasing control points, and extending optimization time.
Optimization log files and dose-volume histograms (DVHs) were analyzed.
Strategies were applied to four head and neck cancer patient plans.

Main Results:

Adjusting maximum leaf speed, adding arcs, and extending optimization time (pausing or continuing) significantly improved plans (p < 0.05).
Improvements in objective function values correlated with better DVHs.
Phantom results were consistent with head and neck cancer cases.

Conclusions:

Optimization log file analysis is valuable for comparing treatment plans.
Proven strategies enhance RapidArc treatment planning for head and neck cancers.
Phantom studies effectively predict clinical outcomes for RapidArc optimization.